STOCK TITAN

Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Zomedica Corp. (ZOM) to Host Business Update Call on January 17, 2024, to Discuss Preliminary 2023 Revenue, Cash Position, and Share Consolidation
Positive
  • None.
Negative
  • None.

ANN ARBOR, MI / ACCESSWIRE / January 10, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced that it will be hosting a conference call on Wednesday, January 17, 2024 at 4:30 p.m. ET.

Management will provide a business update, including preliminary 2023 revenue and cash position, as well as other operational highlights during the call. In addition, the Company will discuss the upcoming Share Consolidation ("reverse stock split") and other matters related to a Special Virtual-Only Meeting of Shareholders to be held on February 28, 2024, at 1:00 p.m. ET.

A question-and-answer session will follow management's prepared remarks.

Event: Zomedica Business Update Call

Date: Wednesday, January 17, 2024

Time: 4:30 p.m. Eastern Time

Live Call: 1-877-407-0789 (U.S. Toll Free) or 1-201-689-8562 (International)

Webcast: Zomedica Business Update Webcast

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Wednesday, January 31, 2024, at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 13743242.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit zomedica.com.

Follow Zomedica

Investor Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View the original press release on accesswire.com

FAQ

When is Zomedica Corp. hosting the business update call?

Zomedica Corp. will host the business update call on Wednesday, January 17, 2024.

What will be discussed during the business update call?

Management will provide a business update, including preliminary 2023 revenue and cash position, as well as other operational highlights.

What is the upcoming event related to Zomedica Corp.?

Zomedica Corp. will hold a Special Virtual-Only Meeting of Shareholders on February 28, 2024, at 1:00 p.m. ET to discuss the Share Consolidation and other matters.

How can interested individuals join the conference call?

Interested individuals can join the conference call by dialing 1-877-407-0789 (U.S. Toll Free) or 1-201-689-8562 (International) at 4:30 p.m. ET on January 17, 2024.

How can individuals access the dial-in replay of the call?

A dial-in replay of the call will be available until January 31, 2024, at 11:59 PM ET, and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 13743242.

Zomedica Corp.

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

118.48M
961.51M
1.78%
8.33%
5.12%
Medical Devices
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR